PRESS RELEASE

Of interest to editors and journalists covering:
Health, Medical, Nutraceuticals, Drugs, NJ Business News

	
Optimal Therapeutics Announces the Signing of a Licensing Agreement with Kwowa Hakko USA for the Ingredient Cognizin(R) to be Included in Their Brain Function Formula Neurovar

CEDAR GROVE, NJ - March 21, 2005 /Send2Press Newswire/ -- Optimal Therapeutics announces the signing of a licensing agreement with Kwowa Hakko USA for the ingredient Cognizin(R) to be included in their brain function formula Neurovar. 

Optimal Therapeutics company spokesperson Camille Westhoff states "Cognizin(R) is an exciting ingredient that immediately places the Neurovar formulation at the top in this competitive class." 

Neurovar also contains other quality ingredients like Phosphatidyl Serine, Bacopa Monniera, Alpha GPC, Ginkgo Biloba, Vinpocetine and Acetyl-L-Carnitine. 

Optimal Therapeutics, a Neutraceutical manufacturer based in New Jersey, also produces Zyroxin, Zalestra, Phosoplex, Fematril, Viastat amongst other quality formulations. Optimal Therapeutics products can be found online at www.BodEStore.com and at Amazon.


# # #


NEWS SOURCE: Optimal Therapeutics

WEBSITE: http://www.BodEStore.com

MEDIA CONTACT(S):

	Deana Piserchia
	of Optimal Therapeutics
	+1-877-723-4665
	sales @ urbanbiologics.com


----------------------------------------------------------------- 

TXT: http://www.Send2Press.com/mediadrome/2005-03-0321-005.txt

PDF: http://www.Send2Press.com/mediadrome/news_2005-03-0321-005.pdf

 Anti-Spam Policy Note for this Archive Copy: 
 if you have received spam email or faxes related to this news story, it did not come from us. View the email headers or fax number where the abuse originated. Send2Press NEVER sends news to the public or to businesses of any kind, only the working MEDIA.
  -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- ------------------------- 
English (lang=en) / Content Copr. (c) 2005 Send2Press Newswire.

This release was issued on behalf of the above organization, 
who is solely responsible for accuracy of content, 
by Send2Press(R) Newswire, a unit of Neotrope(R). 
http://www.Send2Press.com

Web sites may reproduce this release verbatim if the originating
source /Send2Press Newswire/ and Copr. (c) "Send2Press(R)" is retained.


[ related: http://www.eNewsChannels.com ]